Sfoglia per AUTORE
CLERICO M
Collezione AOU San Luigi di Orbassano

  

Items : 45

Anti-CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the R-FolSTOP multicentre Italian study. in Annals of hematology / Ann Hematol. 2025 Mar;104(3):1655-1667. doi: 10.1007/s00277-025-06295-0. Epub 2025 Mar 12.
2025
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Massaia M; Castellino C; Galimberti S; Rattotti S; Annibali O; Conconi A; Margiotta-Casaluci G; Farina L; Meli E; Anastasia A; Bozzoli V; Mecacci B; Bigliardi S; Merli M; Cocito F; Marchesi F; Fanelli F; Perrone T; Clerico M; Nicoli P; Vanazzi A; Boccomini C; Comba L; Bertolotti L; Castellino A;

2024
AOU San Luigi di Orbassano

Cocito D; Peci E; Torrieri MC; Clerico M;

2024
AOU San Luigi di Orbassano

Bronzini M; Maglione A; Rosso R; Masuzzo F; Matta M; Meroni R; Rolla S; Clerico M;

2024
AOU San Luigi di Orbassano

Maida E; Moccia M; Palladino R; Borriello G; Affinito G; Clerico M; Repice AM; Di Sapio A; Iodice R; Spiezia AL; Sparaco M; Miele G; Bile F; Scandurra C; Ferraro D; Stromillo ML; Docimo R; De Martino A; Mancinelli L; Abbadessa G; Smolik K; Lorusso L; Leone M; Leveraro E; Lauro F; Trojsi F; Streito LM; Gabriele F; Marinelli F; et alii...

SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose. in Journal of neurology / J Neurol. 2024 Jan;271(1):24-31. doi: 10.1007/s00415-023-12034-0. Epub 2023 Nov 3.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Tortorella C; Solaro C; Cocco E; Moccia M; Tomassini V; Lanzillo R; Malucchi S; Paolicelli D; De Luca G; Laroni A; Calabrese M; Gajofatto A; Buttari F; Guaschino C; Radaelli M; Fantozzi R; Clerico M; Di Sabatino E; Cavalla P; Nociti V; Lorefice L; Gallo A; Prosperini L; Maniscalco GT; Ragonese P; Ferraro D; Di Filippo M; Gasperini C;

Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Oct;78:104907. doi: 10.1016/j.msard.2023.104907. Epub 2023 Jul 26.
2023
AOU San Luigi di Orbassano

Petracca M; Carotenuto A; Scandurra C; Moccia M; Rosa L; Arena S; Ianniello A; Nozzolillo A; Turrini M; Streito LM; Abbadessa G; Cellerino M; Bucello S; Ferraro E; Mattioli M; Chiodi A; Inglese M; Bonavita S; Clerico M; Cordioli C; Moiola L; Patti F; Lavorgna L; Filippi M; Borriello G; D'Amico E; Pozzilli C; Brescia Morra V; Lanzillo R; et alii...

Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: A Historical Perspective. in Journal of clinical medicine / J Clin Med. 2023 Nov 7;12(22):6961. doi: 10.3390/jcm12226961.
2023
AOU San Luigi di Orbassano

Cocito D; Peci E; Torrieri MC; Clerico M;

Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression. in Journal of clinical medicine / J Clin Med. 2023 Mar 13;12(6):2215. doi: 10.3390/jcm12062215.
2023
AOU San Luigi di Orbassano

Scandurra C; Rosa L; Carotenuto A; Moccia M; Arena S; Ianniello A; Nozzolillo A; Turrini M; Streito LM; Abbadessa G; Ferraro E; Mattioli M; Chiodi A; Maldonato NM; Bonavita S; Clerico M; Cordioli C; Moiola L; Patti F; Lavorgna L; Filippi M; Borriello G; D'Amico E; Pozzilli C; Brescia Morra V; Petracca M; Lanzillo R;

Feeding the gut microbiome: impact on multiple sclerosis. in Frontiers in immunology / Front Immunol. 2023 May 25;14:1176016. doi: 10.3389/fimmu.2023.1176016. eCollection 2023.
2023
AOU San Luigi di Orbassano

Bronzini M; Maglione A; Rosso R; Matta M; Masuzzo F; Rolla S; Clerico M;

Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis. in Frontiers in immunology / Front Immunol. 2023 Jun 19;14:1205879. doi: 10.3389/fimmu.2023.1205879. eCollection 2023.
2023
AOU San Luigi di Orbassano

Maglione A; Francese R; Arduino I; Rosso R; Matta M; Rolla S; Lembo D; Clerico M;

Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Sep 30:jnnp-2022-329657. doi: 10.1136/jnnp-2022-329657.
2022
AOU San Luigi di Orbassano

Landi D; Bovis F; Grimaldi A; Annovazzi PO; Bertolotto A; Bianchi A; Borriello G; Brescia Morra V; Bucello S; Buscarinu MC; Caleri F; Capobianco M; Capra R; Cellerino M; Centonze D; Cerqua R; Chisari CG; Clerico M; Cocco E; Cola G; Cordioli C; Curti E; d'Ambrosio A; D'Amico E; De Luca G; Di Filippo M; Di Lemme S; Fantozzi R; Ferraro D; et alii...

Source of medical information and behavioral seeking patterns in patients affected with Friedreich's ataxia and their caregivers: a survey study. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2022 May;43(5):3223-3229. doi: 10.1007/s10072-021-05738-6. Epub 2021 Nov 28.
2022
AOU San Luigi di Orbassano

Miele G; Lavorgna L; De Mercanti SF; Iudicello M; Abbadessa G; Matta M; Bonavita S; Clerico M; Miele G; Lavorgna L; De Mercanti SF; Iudicello M; Abbadessa G; Matta M; Bonavita S; Clerico M;

A real-world study of alemtuzumab in a cohort of Italian patients. in European journal of neurology / Eur J Neurol. 2022 Jan;29(1):257-266. doi: 10.1111/ene.15121. Epub 2021 Oct 5.
2022
AOU San Luigi di Orbassano

Russo CV; Saccà F; Frau J; Annovazzi P; Signoriello E; Bonavita S; Grasso R; Clerico M; Cordioli C; Laroni A; Capobianco M; Torri Clerici V; Sartori A; Cavalla P; Maniscalco GT; La Gioia S; Caleri F; Giugno A; Iodice R; Carotenuto A; Cocco E; Fenu G; Zaffaroni M; Baroncini D; Lus G; Gallo A; De Mercanti SF; Lapucci C; Di Francescantonio V; et alii...

mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Apr;93(4):448-450. doi: 10.1136/jnnp-2021-327200. Epub 2021 Aug
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Tortorella C; Cocco E; Gasperini C; Solaro C; Gazzola P; Gallo A; Maniscalco GT; Paolicelli D; Calabrese M; Borrelli A; Tomassini V; De Luca G; Clerico M; Boffa L; Lanzillo R; Moccia M; Ferraro D; Gajofatto A; Prosperini L; Fantozzi R; Buttari F; Laroni A; Lorefice L; Radaelli M; Nociti V; Torri Clerici V; Cavalla P; Annovazzi P; Malucchi S; et alii...

MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study. in Journal of the neurological sciences / J Neurol Sci. 2021 May 15;424:117385. doi: 10.1016/j.jns.2021.117385. Epub 2021 Mar 6.
2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sartori A; Frangiamore R; Laroni A; Gandoglia I; Lanzillo R; Petruzzo M; Landi D; Mataluni G; Baroncini D; Mirabella M; Nociti V; Cocco E; Lorefice L; Maniscalco GT; Curti E; Lavorgna L; Abbadessa G; Bonavita S; Lus G; Signoriello E; Cordioli C; Signori A; De Mercanti SF; Cavalla P; Costantini G; Capra R; Sormani MP; Clerico M;

Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series. in Frontiers in neurology / Front Neurol. 2021 Oct 20;12:691616. doi: 10.3389/fneur.2021.691616. eCollection 2021.
2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Cavalla P; Clerico M; Schillaci V; Bosa C; Alteno A; De Mercanti SF; Vercellino M;

Cladribine vs other drugs in MS: Merging randomized trial with real-life data. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2020 Aug 14;7(6):e878. doi: 10.1212/NXI.0000000000000878. Print 20
2020
ASL Cuneo 1
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sormani MP; Visconti A; Landi D; Ippolito D; Esposito S; Russo CV; Barrilà C; Barone S; Grasso R; Pontecorvo S; Di Sapio A; Stromillo ML; Cordioli C; Rasia S; Sartori A; Clerici VT; Fenu G; Cocco E; Frau J; Barcella V; Frigeni B; La Gioia S; Pareja-Gutierrez L; Laroni A; Zarbo IR; Lavorgna L; Bonavita S; Perini P; Mataluni G; et alii...

First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2020 Jul;42:102059. doi: 10.1016/j.msard.2020.102059. Epub 2020 Mar 16.
2020
ASL Cuneo 1
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Signori A; Sormani MP; Carmisciano L; Turano G; Ippolito D; Russo CV; Frigeni B; Landi D; Barrilà C; Barone S; Lavorgna L; Grasso R; Di Sapio A; Cerqua R; Pontecorvo S; Stromillo ML; Cordioli C; Signoriello E; Rasia S; Sartori A; Zarbo IR; Laroni A; Frau J; Cocco E; Torri Clerici V; La Gioia S; Gutierrez LP; Clerico M; Mataluni G; et alii...

Atypical Multiple Sclerosis Lesions or Progressive Multifocal Leukoencephalopathy Lesions: That Is the Question. in Journal of investigative medicine high impact case reports / J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620939802. doi: 10.1177/2324709620939802.
2020
AOU San Luigi di Orbassano

Matta M; Iudicello M; Gned D; De Mercanti SF; Franchin E; Clerico M;

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics / Neurotherapeutics. 2020 Jan;17(1):200-207. doi: 10.1007/s13311-019-00776-7.
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sartori A; Laroni A; Frangiamore R; Gandoglia I; Lanzillo R; Petruzzo M; Landi D; Mataluni G; Baroncini D; Mirabella M; Nociti V; Lorefice L; Cocco E; Curti E; Maniscalco GT; Lavorgna L; Bonavita S; Lus G; Signoriello E; Cordioli C; Signori A; Iudicello M; De Mercanti SF; Clerico M; Cavalla P; Costantini G; Sormani MP; Capra R;

Sex effects across the lifespan in women with multiple sclerosis. in Therapeutic advances in neurological disorders / Ther Adv Neurol Disord. 2020 Jul 1;13:1756286420936166. doi: 10.1177/1756286420936166. eCollection 2
2020
AOU San Luigi di Orbassano

Krysko KM; Graves JS; Dobson R; Altintas A; Amato MP; Bernard J; Bonavita S; Bove R; Cavalla P; Clerico M; Corona T; Doshi A; Fragoso Y; Jacobs D; Jokubaitis V; Landi D; Llamosa G; Longbrake EE; Maillart E; Marta M; Midaglia L; Shah S; Tintore M; van der Walt A; Voskuhl R; Wang Y; Zabad RK; Zeydan B; Houtchens M; et alii...

Outcomes after fingolimod to alemtuzumab treatment shift in relapsing-remitting MS patients: a multicentre cohort study. in Journal of neurology / J Neurol. 2019 Oct;266(10):2440-2446. doi: 10.1007/s00415-019-09424-8. Epub 2019 Jun 17.
2019
AOU San Luigi di Orbassano

Frau J; Saccà F; Signori A; Baroncini D; Fenu G; Annovazzi P; Capobianco M; Signoriello E; Laroni A; La Gioia S; Sartori A; Maniscalco GT; Bonavita S; Clerico M; Russo CV; Gallo A; Lapucci C; Carotenuto A; Sormani MP; Cocco E;

Right phrenic nerve palsy following transcatheter radiofrequency current atrial fibrillation ablation: Case report. in The Journal of international medical research / J Int Med Res. 2019 Jul;47(7):3438-3443. doi: 10.1177/0300060519849267. Epub 2019 May 30.
2019
AOU San Luigi di Orbassano

Abbadessa G; Lavorgna L; Cirillo G; Clerico M; Todisco V; Cirillo M; Trojsi F; Tedeschi G; Bonavita S;

Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2019 Apr;25(4):591-600. doi: 10.1177/1352458518763080. Epub 2018 Mar 20.
2019
AOU San Luigi di Orbassano

Lavie C; Rollot F; Durand-Dubief F; Marignier R; Ionescu I; Casey R; Moreau T; Tourniaire P; Hutchinson M; D'Hooghe MB; Laplaud DA; Clavelou P; De Sèze J; Debouverie M; Brassat D; Pelletier J; Lebrun-Frenay C; Le Page E; Castelnovo G; Berger E; Hautecoeur P; Heinzlef O; Durelli L; Clerico M; Trojano M; Patti F; Vukusic S;

e-Health and multiple sclerosis: An update. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2018 Nov;24(13):1657-1664. doi: 10.1177/1352458518799629. Epub 2018 Sep 19.
2018
AOU San Luigi di Orbassano

Lavorgna L; Brigo F; Moccia M; Leocani L; Lanzillo R; Clerico M; Abbadessa G; Schmierer K; Solaro C; Prosperini L; Tedeschi G; Giovannoni G; Bonavita S;

Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2017 May;23(6):874-876. doi: 10.1177/1352458516688350. Epub 2017 Feb 1.
2017
AOU San Luigi di Orbassano

Clerico M; De Mercanti S; Artusi CA; Durelli L; Naismith RT;

Lack of CD4+ T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses. in Journal of neuroimmunology / J Neuroimmunol. 2017 Dec 15;313:89-91. doi: 10.1016/j.jneuroim.2017.10.009. Epub 2017 Oct 17.
2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Clerico M; Durelli L; Novelli F; Vladic A; Annovazzi P; Cocco E; Adamec I; Habek M; Horakova D; Bardina V; Rolla S; De Mercanti SF;

Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis. in The Cochrane database of systematic reviews / Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD012200. doi: 10.1002/14651858.CD012200.pub2.
2017
AOU San Luigi di Orbassano

Filippini G; Del Giovane C; Clerico M; Beiki O; Mattoscio M; Piazza F; Fredrikson S; Tramacere I; Scalfari A; Salanti G;

Influence of cigarette smoking on ALS outcome: a population-based study. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1229-1233. doi: 10.1136/jnnp-2016-313793. Epub 2016 S
2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Mazzini L; Mora G; Pisano F; Bottacchi E; Marinou K; Moglia C; Ilardi A; Manera U; Cammarosano S; Bersano E; De Mercanti S; Clerico M; Bertuzzo D; Cugnasco P; Solero L; Chiò A; Calvo A; Canosa A;

Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon ?-1a using an electronic device: the RIVER study. in Expert opinion on drug delivery / Expert Opin Drug Deliv. 2016 Jul;13(7):931-5. doi: 10.1517/17425247.2016.1148029. Epub 2016 Feb 24.
2016
AOU San Luigi di Orbassano

Lugaresi A; De Robertis F; Clerico M; Brescia Morra V; Centonze D; Borghesan S; Maniscalco GT;

Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2016 Jan 21;3(1):e194. doi: 10.1212/NXI.0000000000000194. eCollect
2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Clerico M; Durelli L; Novelli F; Annovazzi P; Horakova D; Adamec I; Habek M; Soldo-Butkovic S; Vladic A; Cocco E; Bardina V; Cucci A; Rolla S; De Mercanti S;

Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia. in Journal of neurology / J Neurol. 2015 Dec;262(12):2662-7. doi: 10.1007/s00415-015-7894-1. Epub 2015 Sep 26.
2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Durelli L; Chio' A; Calvo A; Avagnina P; Veltri A; Cucci A; De Mercanti S; Artusi CA; Tinivella M; Busso M; Barbero P; Clerico M;

Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study. in JAMA neurology / JAMA Neurol. 2014 Sep;71(9):1134-42. doi: 10.1001/jamaneurol.2014.1129.
2014
AOU San Luigi di Orbassano

Chiò A; Calvo A; Bovio G; Canosa A; Bertuzzo D; Galmozzi F; Cugnasco P; Clerico M; De Mercanti S; Bersano E; Cammarosano S; Ilardi A; Manera U; Moglia C; Sideri R; Marinou K; Bottacchi E; Pisano F; Cantello R; Mazzini L; Mora G;

Th22 cells are expanded in multiple sclerosis and are resistant to IFN-?. in Journal of leukocyte biology / J Leukoc Biol. 2014 Dec;96(6):1155-64. doi: 10.1189/jlb.5A0813-463RR. Epub 2014 Aug 5.
2014
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Durelli L; Novelli F; De Palma R; Gned D; Brusa D; Quaglino P; De Mercanti S; Bardina V; Rolla S; Clerico M;

2014
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Paolicelli D; Cavalla P; Sola P; Vitetta F; Realmuto S; Salemi G; Bianchi A; Ghezzi A; Lanzillo R; Brescia Morra V; Gned D; Piazza F; De Mercanti SF; Schiavetti I; Clerico M; Trojano M; Sormani MP; Durelli L;

Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose. in Journal of neuroimmunology / J Neuroimmunol. 2010 Sep 14;226(1-2):150-7. doi: 10.1016/j.jneuroim.2010.05.038. Epub 2010 Jun 23.
2010
AOU San Luigi di Orbassano

Cucci A; Barbero P; Clerico M; Ferrero B; Versino E; Contessa G; Demercanti S; Viglietta E; Di Liberto A; Vai AG; Durelli L;

T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. in Annals of neurology / Ann Neurol. 2009 May;65(5):499-509. doi: 10.1002/ana.21652.
2009
AOU San Luigi di Orbassano

Durelli L; Conti L; Clerico M; Boselli D; Contessa G; Ripellino P; Ferrero B; Eid P; Novelli F;

Neutralizing antibodies in multiple sclerosis patients treated with 375 micrograms interferon-beta-1b. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2009 Apr;9(4):387-97. doi: 10.1517/14712590902762781.
2009
AOU San Luigi di Orbassano

Durelli L; Barbero P; Cucci A; Ferrero B; Ricci A; Contessa G; De Mercanti S; Ripellino P; Lapuma D; Viglietta E; Bergui M; Versino E; Clerico M;

The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders. in Journal of neurology / J Neurol. 2008 Sep;255(9):1315-23. doi: 10.1007/s00415-008-0879-6. Epub 2008 Sep 25.
2008
AOU San Luigi di Orbassano

Durelli L; Barbero P; Bergui M; Versino E; Bassano MA; Verdun E; Ferrero B; Rivoiro C; Ferrero C; Picco E; Ripellino P; Viglietti D; Giuliani G; Montanari E; Clerico M;

MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):646-51. doi: 10.1136/jnnp.2007.130229. Epub 2007 Nov 6
2008
AOU San Luigi di Orbassano

Durelli L; Barbero P; Bergui M; Versino E; Bassano MA; Verdun E; Rivoiro C; Ferrero C; Picco E; Ripellino P; Giuliani G; Montanari E; Clerico M; Durelli L; Barbero P; Bergui M; Versino E; Bassano MA; Verdun E; Rivoiro C; Ferrero C; Picco E; Ripellino P; Giuliani G; Montanari E; Clerico M;

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis. in The Cochrane database of systematic reviews / Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005278. doi: 10.1002/14651858.CD005278.pub3.
2008
AOU San Luigi di Orbassano

Clerico M; Faggiano F; Palace J; Rice G; Tintorè M; Durelli L;

Interferon-beta1a for the treatment of multiple sclerosis. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2007 Apr;7(4):535-42. doi: 10.1517/14712598.7.4.535.
2007
AOU San Luigi di Orbassano

Clerico M; Contessa G; Durelli L;

The importance of maintaining effective therapy in multiple sclerosis. in Journal of neurology / J Neurol. 2005 Sep;252 Suppl 3:iii38-iii43. doi: 10.1007/s00415-005-2016-0.
2005
AOU San Luigi di Orbassano

Durelli L; Clerico M;

2004
AOU San Luigi di Orbassano

Barbero P; Verdun E; Bergui M; Pipieri A; Clerico M; Cucci A; Ricci A; Bergamasco B; Durelli L;

Combination chemotherapy with carboplatin and methotrexate in the treatment of advanced urothelial carcinoma. A phase II study. in American journal of clinical oncology / Am J Clin Oncol. 1995 Feb;18(1):78-82. doi: 10.1097/00000421-199502000-00017.
1995
AOU San Luigi di Orbassano

Dogliotti L; Bertetto O; Berruti A; Clerico M; Fanchini L; Sicora W; Faggiuolo R;